Translating ctDNA into cutaneous melanoma care: An international expert survey.
Saved in:
| Title: | Translating ctDNA into cutaneous melanoma care: An international expert survey. |
|---|---|
| Authors: | Geidel G; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: g.geidel@uke.de., Fekade N; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Raabe K; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Smit DJ; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Adam L; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Heidrich I; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rünger A; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kött J; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Zell T; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Amaral T; Centre Paul Strauss, Strasbourg, France., Ascierto PA; Department of Neuroscience, Reproductive and Dental Sciences, Università degli Studi di Napoli 'Federico II', Napoli, Italy; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics - Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy., Corrie P; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK., Dummer R; Department for Dermatology, University Hospital Zurich, Zurich, Switzerland., Eggermont A; Princess Máxima Center and the University Medical Center Utrecht, Heidelberglaan 25, Utrecht 3584, the Netherlands; Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig Maximilian University, Munich, Germany., Guo J; Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, Peking, China., Hassel JC; Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany., Jalving M; Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands., Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Kandolf L; Dermatology Department, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia., Kirkwood JM; University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, USA., Lebbé C; Université Paris Cité, AP-HP Dermato-oncology and CIC, Cancer institute APHP.nord Paris cité, INSERM U1342 - Equipe 1 - CNRS EMR8000, Saint Louis Hospital, Paris, France., Lee R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Long GV; Department of Medical Oncology, Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia., Lorigan P; The University of Manchester, Oxford Rd, Manchester M13 9PL, United Kingdom., Malvehy J; Department of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain., Mangana J; Department for Dermatology, University Hospital Zurich, Zurich, Switzerland., Mohr P; Department of Dermatology, Elbe-Kliniken Buxtehude, Buxtehude, Germany., Patel SP; University of Colorado Cancer Center, Departments of Medicine & Ophthalmology, Aurora, CO, USA., Rizos H; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia., Robert C; Institut Gustave Roussy, Dermatology Department, 114 Rue Édouard Vaillant, Villejuif 94800, France., Schadendorf D; Department of Dermatology and Venereology, University Hospital Essen, Essen, Germany., Sondak VK; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA., Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Wainstein A; Faculdade de Ciências Médicas de Minas Gerais, Pós-Graduação, Belo Horizonte, MG, Brasil., Zager JS; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, 10920 McKinley Dr, Tampa, FL 33612, USA., Pantel K; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hauschild A; Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany., Gebhardt C; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: ch.gebhardt@uke.de. |
| Corporate Authors: | Melanoma World Society Study Group |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 May 15; Vol. 239, pp. 116676. Date of Electronic Publication: 2026 Mar 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
